A combination of genetic tests for a "very complex" blood cancer could accurately predict if the disease is likely to return ...
It is hoped it will allow medics to better understand how cancer cells are behaving before planning treatment.
Novel therapies for certain autoimmune diseases have been developed to end B cell-driven immune attacks on normal tissues.
Ciltacabtagene autoleucel (cilta-cel; Carvykti) for multiple myeloma has a new boxed warning for immune effector ...
Cancer is classified as the uncontrollable growth of mutated cells. There are different types of cancers that correlate to ...
The U.S. Food and Drug Administration on Friday approved labeling changes for Johnson & Johnson and its partner Legend ...
The U.S. Food and Drug Administration (FDA) has updated the safety labeling for Carvykti, the multiple myeloma therapy ...
A group of runners will set off from York this weekend in support of an Army Major, from Catterick Garrison, who has been ...